Literature DB >> 24274237

Prevalence of symptoms and associated comorbidities of testosterone deficiency syndrome in the Korean general population.

Du Geon Moon1, Jin Wook Kim, Je Jong Kim, Kwang Sung Park, Jong Kwan Park, Nam Cheol Park, Sae Woong Kim, Sung Won Lee.   

Abstract

INTRODUCTION: Testosterone deficiency syndrome (TDS) is a prevalent disease of the aging male with much confusion to its associated presentation, diagnosis, and comorbidities. AIM: We investigated the overall prevalence of TDS and its putative symptoms and associated diseases in a nationwide study on participants recruited from routine checkup.
METHODS: One thousand eight hundred seventy-five participants seeking biennial health checkup were enrolled from a nationwide distribution of randomly selected registry of primary clinics. Putative symptoms and comorbidities were assessed for serum testosterone-dependent prevalence change, independent of age. The identified symptoms were then assessed by multivariate backward stepwise binominal regression to determine the optimal reference level of testosterone and the strength of the associated comorbidities. MAIN OUTCOME MEASURES: TDS was assessed by serum testosterone, the Aging Males' Symptom scale, and the Androgen Deficiency in Aging Male questionnaire. Patient body habitus measurements and history of associated comorbidities were also described. The dependent variables included the age-specific prevalence of decreased testosterone and the probability of TDS-specific symptoms.
RESULTS: Grossly 10.2% of the participants fell into the criteria for TDS. Testosterone was highly age dependent, and most putative symptoms of TDS showed significant age dependence but was not affected by serum testosterone levels. However, the symptoms of decreased libido and erectile dysfunction, and comorbidities such as hypertension, type 2 diabetes, and obesity showed relevant dependence on serum testosterone levels as well as age above 50 years of age. Furthermore, these symptoms were also affected at different serum testosterone thresholds. Decreased libido increased significantly at serum testosterone levels of 550 ng/dL (odds ratio [OR] = 1.295, 95% confidence interval [CI] = 1.047-1.601), and erectile dysfunction was affected by serum testosterone levels at 250 ng/dL (OR = 1.369, 95% CI = 1.005-1.866).
CONCLUSIONS: Most symptoms and diseases thought to be associated with TDS are primarily age dependent. Few sexual symptoms and diseases such as hypertension, diabetes, and obesity show testosterone dependence only at older ages.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Hypogonadism; Prevalence; Testosterone; Testosterone Deficiency Syndrome

Mesh:

Substances:

Year:  2013        PMID: 24274237     DOI: 10.1111/jsm.12393

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  3 in total

1.  The prevalence of erectile dysfunction among subjects with late-onset hypogonadism: a population-based study in China.

Authors:  Wen-Hao Tang; Xin-Jie Zhuang; Ru-Ming Shu; Di Guan; Yu-Dang Ji; Bao-Long Zhang; Can-Gang Wang; Li-Hua Zhuang; Zhuo Yang; Kai Hong; Lu-Lin Ma; Hui Jiang; Shan-Jie Zhou; Yi-Qun Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men.

Authors:  Xubo Shen; Ruifeng Wang; Na Yu; Yongjun Shi; Honggang Li; Chengliang Xiong; Yan Li; Ellen M Wells; Yuanzhong Zhou
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

3.  Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population.

Authors:  Jong Wook Kim; Young Dae Bae; Sun Tae Ahn; Jin Wook Kim; Je Jong Kim; Du Geon Moon
Journal:  Sex Med       Date:  2018-04-26       Impact factor: 2.491

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.